Biomarkers for determining sensitivity of breast cancer...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/50 (2006.01) G01N 33/532 (2006.01) G01N 33/533 (2006.01) G01N 33/535 (2006.01) G01N 33/543 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2761777

The present invention provides compositions and methods for detecting the expression and/or activation states of components of signal transduction pathways in cells such as tumor cells. Information on the expression and/or activation states of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.

La présente invention concerne des compositions et des procédés permettant de détecter l'expression et/ou l'état d'activation de composants de voies de transduction de signaux dans des cellules telles que les cellules tumorales. Des informations relatives à l'expression et/ou à l'état d'activation de composants de voies de transduction de signaux issues de la mise en uvre de la présente invention peuvent être utilisées en matière de diagnostic et de pronostic dans le domaine des cancers, ainsi que dans le cadre de la conception de traitements anticancéreux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Biomarkers for determining sensitivity of breast cancer... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biomarkers for determining sensitivity of breast cancer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for determining sensitivity of breast cancer... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1673568

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.